平特五不中

Repressing a faulty gene

18 Mar 2024

A study underway at The Neuro is the first in Canada to evaluate whether a treatment using an antisense oligonucleotide therapy would be effective against Creutzfeldt-Jakob Disease.

A neurological disease paradigm shift

Published: 23 January 2024

Researchers propose a new model for classifying Parkinson鈥檚...

Neurodegenerative gene focus of new Open Science project

15 Dec 2023

A new project led by scientists at The Neuro is zeroing in on a gene important to the study of neurological diseases.

Frequent genetic cause of late-onset ataxia uncovered by a Quebec-led international collaboration

Published: 15 December 2022

Discovery will improve diagnosis and open treatment possibilities for thousands of people with this debilitating neurodegenerative condition worldwide...

Genomic research should work for African ancestry populations too

4 Apr 2023

Increased funding and more international collaboration would probably help boost ongoing representation efforts.

Ending the diagnostic odyssey

26 Jan 2023

A new genetic study in New England Journal of Medicine offers hope for thousands with debilitating late-onset gait disorder.

1st National Neurogenetic Variant Interpretation Course (Virtual Course)

Monday, November 28, 2022 12:00to13:30

Who should attend听The review course is aimed at practicing听neurologists, neurology residents and fellows听across Canada who are interested in a comprehensive review of the current clinical genetic...

Day in the Life: Meet a rare disease genetic counsellor

16 Feb 2022

The Neuro鈥檚 Nancy Anoja gives us a look into her work and motivations, and shares a message for people living with rare neurological diseases

Pages

The Neuro logo平特五不中 logo

The Neuro (Montreal Neurological Institute-Hospital)听is a bilingual academic healthcare institution. We are a听平特五不中 research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the 平特五不中 Health Centre.听We are听proud to be a Killam Institution, supported by the Killam Trusts.

Back to top